Company news
Underwood Capital Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Harvest One Operational Update
February 6, 2018
Harvest One Corporate Update
January 31, 2018
Quarterly Update and Appendix 4C
January 31, 2018
PhytoTech Therapeutics Phase 2 Clinical Trial Update
January 30, 2018
MMJ to Acquire Strategic Position in Dosecann Inc
January 29, 2018
Harvest One Announces C$35 Million Financing
January 9, 2018
Federal Government Approves Medicinal Cannabis Exports
January 4, 2018
MMJ Finalises C$2 Million Weed Me Inc. Investment
December 28, 2017
Strategic Investment in Weed Me Inc.
December 11, 2017
Harvest One Financing Update
November 21, 2017
MMJ Clinical Trial Results Published in Medical Journal
November 15, 2017
Commits A$500,000 Cornerstone Investment in eSense-Lab
November 13, 2017
Satipharm Patent Application Update
August 23, 2017
MMJ Receives Approval to Conduct MS Phase 2 Clinical Trials
May 14, 2017
Completion of First Shipment of MC Products into Australia
May 8, 2017
Harvest One Signs Funding Agreements with PanCann
May 2, 2017
Harvest One Listing
April 27, 2017
Harvest One Receives Conditional TSX-V Listing Approval
April 25, 2017
First Cannabis Crop Harvested at Duncan Facility
April 5, 2017
Canada Set to Legalise Recreational Cannabis By July 2018
March 28, 2017
Satipharm Sales Update
March 12, 2017
Land Lease Agreement Expands Duncan Production Capacity
March 8, 2017
HL Pharma Submits Australian Import Licence Appllication
February 27, 2017
Harvest One Closes C$25M Placement
February 22, 2017
MMJ Enters Agreement to Strengthen AUS Distribution Network
February 12, 2017
Response to ASX Aware Query
February 2, 2017
Harvest One Increases Equity Raising to C$25M
January 30, 2017
United Greeneries Commences Cannabis Cultivation
December 21, 2016
Company Update - Q&A Session with Managing Director
December 19, 2016
MMJ Signs Definitive Agreement with Harvest One
December 7, 2016
United Greeneries Receives Cannabis Seed Import Permit
November 27, 2016
MMJ Receives Superior Offer To List Core Assets on TSX-V
November 2, 2016
MMJ Raises $4 Million in an Over-Subscribed Share Placement
October 10, 2016
MMJ Core Cannabis Brands to List on TSX-V via RTO
September 28, 2016
MMJ to Commence Phase 2 Clinical Trial on Pediatric Epilepsy
August 14, 2016
MMJ Enters Strategic Land Package Agreement
August 2, 2016
Canada Takes Steps Towards Recreational Legalisation
July 4, 2016
Health Canada Grants MMJ License to Produce Medical Cannabis
June 29, 2016
MMJ Marks AUS Market Entry with Two Strategic Partnerships
April 19, 2016
Progress on MMJs Lucky Lake Facility MMPR Application
March 29, 2016
Satipharm Gelpell Outperforms Sativex in Phase 1 Trial
March 2, 2016
Capital Raising
February 29, 2016
Cannabis Legalisation Gives MMJ the Green Light
February 24, 2016
Successful Results of Phase 1 Clinical Trial
February 11, 2016
Extension of Yissum Licensing Agreement
February 10, 2016
Decks
The 5 newest of 7 decks. Every deck is listed under its year.
- Shareholder Meeting (November 2025)
Shareholder meeting · 23 slides · Nov 27, 2025
- FY2025 Earnings Presentation
Earnings · 8 slides · Aug 25, 2025
- H1 FY2025 Earnings Presentation
Earnings · 9 slides · Feb 20, 2025
- Investor Presentation (June 2021)
Investor deck · 18 slides · June 2021
- Investor Presentation (September 2020)
Investor deck · 5 slides · September 2020